A study of 880 men found clinically significant prostate cancer [...]

A new AI model has generated patient-specific radiation dose-rate maps [...]

Telix Pharmaceuticals has received FDA agreement on the protocol and [...]

CuraCell TX has reported new findings supporting its personalised tumour-infiltrating [...]

Phase 3 data presented at ASCO 2026 suggest a PSMA-targeted [...]

Kairos Pharma, Ltd. will present positive safety and early efficacy [...]

XenoSTART and Minerva Imaging have expanded their long-standing partnership to [...]

Inaphaea BioLabs, the translational contract research organisation (CRO) of ValiRx [...]

Kairos Pharma has announced encouraging interim efficacy results from its [...]

VIVES Partners, managing company of VIVES Funds, has joined a [...]